Molimard, Mathieu
Mathieu Molimard pharmacologue français
VIAF ID: 172934234 (Personal)
Permalink: http://viaf.org/viaf/172934234
Preferred Forms
- 100 0 _ ‡a Mathieu Molimard ‡c pharmacologue français
- 200 _ | ‡a Molimard ‡b Mathieu
-
- 100 1 _ ‡a Molimard, Mathieu
- 100 1 _ ‡a Molimard, Mathieu
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Apport analytique de la spectrométrie de masse haute résolution en QTOF pour l'identification et la prise en charge de l'exposition aux substances psychoactives | |
Approche pharmaco-épidémiologique de la douleur chronique neuropathique en France et évaluation d'une nouvelle stratégie thérapeutique : intérêt de l'agomélatine | |
bon usage du médicament et des thérapeutiques non médicamenteuses ouvrage officiel des enseignants | |
Calibration and Validation of a New Method of Causality Assessment in Adverse Drug Reaction. | |
Comparative analysis of costs and efficacy of treatments in metastatic renal cell carcinoma : trial based and real life based analyses. | |
Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study. | |
Les conflits d’intérêts dans le domaine des produits et de technologies de santé : état des lieux et recommandations | |
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension. | |
Determinants of the efficacy and toxicity of kinase inhibitors used for the treatment of metastatic melanoma. | |
Développement d'une méthode de dosage d'un pesticide, le folpel, et de ses produits de dégradation dans les liquides biologiques : application toxicocinétique chez le rat | |
Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID Study | |
Effect of indacaterol, a novel long-acting beta2-agonist, on isolated human bronchi. | |
Efficiency and safety of oxcarbazepine in mood disorders: a naturalistic study exploring the interest of plasma dosages. | |
Elaboration et validation d'une nouvelle méthode d'imputabilité en pharmacovigilance | |
Évaluation clinique des innovations thérapeutiques en situation réelle de soin dans la prise en charge du mélanome métastatique | |
Evaluation de l'efficacité des sutures avec triclosan sur les micro-organismes associés aux infections de site opératoire | |
Evaluation du mésusage des benzodiazépines et de ses conséquences chez les patients atteints de pathologies psychiatriques | |
Français : secrétariat médical et médicosocial, 2me année : [séries 09 à 12, devoirs D 09-11-12] | |
The French Levothyrox® crisis: We did the best we could but… | |
Fully automated analytical method for mycophenolic acid quantification in human plasma using on-line solid phase extraction and high performance liquid chromatography with diode array detection | |
Gender and interindividual variability in pharmacokinetics. | |
Guidance on handheld inhalers in asthma and COPD guidelines | |
Health-related factors and road safety : influence of medicine use (The CESIR-A study). | |
Highly sensitive LC-MS/MS methods for urinary biological monitoring of occupational exposure to cyclophosphamide, ifosfamide, and methotrexate antineoplastic drugs and routine application | |
How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database | |
Imatinib assay by HPLC with photodiode-array UV detection in plasma from patients with chronic myeloid leukemia: Comparison with LC-MS/MS. | |
Information and communication on risks related to medications and proper use of medications for healthcare professionals and the general public: precautionary principle, risk management, communication during and in the absence of crisis situations | |
Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation. | |
Inhaled Medication Compliance in Asthma and Chronic Obstructive Pulmonary Disease (COPD) : Effect of Combination in a single Inhaler of the Long-acting β 2-Adrenergic (LABA) and the Inhaled Corticosteroi͏̈d (ICS). | |
Initiation à la connaissance du médicament : UE6 | |
Integrated care pathways for airway diseases (AIRWAYS-ICPs). | |
Interest of pharmacoepidemiology for the study of inhaled drugs | |
Large-scale imatinib dose-concentration-effect study in CML patients under routine care conditions. | |
L'observance des thérapies inhalées dans l'asthme et la bronchopneumopathie chronique obstructive : l'effet des associations fixes de β 2 mimétique longue durée d'action et corticoi͏̈de inhalés | |
Long-acting beta2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic leukaemia cells. | |
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. | |
Mécanisme d'action de la bradykinine sur les voies aériennes : application à l'analyse des effets protecteurs du furosémide dans l'asthme | |
A method to measure deferasirox in plasma using HPLC coupled with MS/MS detection and its potential application. | |
Mise au point et validation d'une méthode de détection et quantification des cannabinoïdes de synthèse dans les urines : application à une cohorte de patients | |
A new method for assessing drug causation provided agreement with experts' judgment. | |
[The nocebo effect: Various aspects and consequences in clinical practice] | |
An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France | |
Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control | |
Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study. | |
Pharmacological determinants of the effectiveness of tyrosine kinases inhibitors. | |
Pharmacologie, bon usage du médicament, UE 10 | |
Phase I study of axitinib and everolimus in metastatic solid tumours and extension to metastatic renal cell carcinoma: Results of EVAX study. | |
A phase II study for the evaluation of quinine as a modulator of multidrug resistance in non-Hodgkin’s lymphoma | |
Phénotypes et trajectoires des patients BPCO, données issues de la cohorte PALOMB | |
Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy | |
Postmortem redistribution of two antipsychotic drugs, haloperidol and thioridazine, in the rat | |
The prognostic impact of psychotropic drugs in intentional drug overdose. | |
Quantification methods of folpet degradation products in plasma with HPLC-UV/DAD: application to an in vivo toxicokinetic study in rats. | |
Quantification of eight new antidepressants and five of their active metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry. | |
[Real-life use of inhaler devices for chronic obstructive pulmonary disease in primary care] | |
Relations entre alimentation et maladies allergiques de l'enfant : étude libanaise et étude française | |
Relationship between diet and allergic diseases of the child : lebanese study and french study. | |
[Respiratory therapy in the elderly: from preventive treatment (vaccines) to curative treatments] | |
Rivaroxaban and apixaban in orthopaedics: is there a difference in their plasma concentrations and anticoagulant effects? | |
Role of tachykinins as contractile agonists of human airways in asthma. | |
Santé et insécurité routière : influence de la consommation de médicaments (Étude CESIR-A) | |
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) | |
Scientific Rationale for Determining the Bioequivalence of Inhaled Drugs. | |
Simplified ultraviolet liquid chromatographic method for determination of sertindole, dehydrosertindole and norsertindole, in human plasma. | |
Simultaneous determination of nine tyrosine kinase inhibitors by 96-well solid-phase extraction and ultra performance LC/MS-MS | |
SR 142801, a tachykinin NK(3) receptor antagonist, prevents beta(2)-adrenoceptor agonist-induced hyperresponsiveness to neurokinin A in guinea-pig isolated trachea. | |
The sustainable impact of an educational approach to improve the appropriateness of laboratory test orders in the ICU | |
Therapeutic drug monitoring of imatinib in chronic myeloid leukemia: experience from 1216 patients at a centralized laboratory. | |
Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD. | |
Treatment of advanced gastrointestinal stromal tumors in patients over 75 years old: clinical and pharmacological implications. | |
[Treatment of erectile dysfunction by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy | |
Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma. | |
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia | |
Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD. | |
Underdiagnosis of nocturnal symptoms in asthma in general practice | |
Use of reimbursement claims databases for the measurement of medication adherence. | |
Utilisation des bases de données de remboursement dans la mesure de l'observance des médicaments | |
Value of post-registration studies for reimbursement renewal. |